ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1624411
This article is part of the Research TopicNext-Generation Technologies for Antibiotic Susceptibility TestingView all articles
Evaluation of PhenoMATRIX® PLUS for the culture-based rectal screening of CPOs, ESBL-E, Acinetobacter, and VRE carriage
Provisionally accepted
- Hôpitaux universitaires de Genève (HUG), Genève, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Multidrug-resistant organisms (MDROs) have become a serious public health concern worldwide. Screening for MDROs can encompass various phenotypic and genotypic approaches. Recently, culture-based MDROs screening has substantially benefitted from laboratory automation and artificial intelligence. Objectives: To evaluate the performance of PhenoMATRIX® PLUS for an institutionwide culture-based rectal screening for CPOs, ESBL-E, Acinetobacter, and VRE carriage. Methods: The number of non-duplicated rectal Eswabs specimens used to generate culture plate images for the PhenoMATRIX® PLUS machine learning phase amounted to 2'900 for chromID™ ESBL agar, 2'403 for chromID™ OXA-48 agar, 2'031 for CHROMagar TM Acinetobacter agar, and 9'333 for chromID™ VRE agar. All such plates and images were classified by manual reading as either positive or negative. The validation of the settings derived during the learning phase was achieved on an additional 4'517 non-duplicate specimens. Digital images of 22'585 media plates (i.e., five per specimen) were prospectively analyzed by PhenoMATRIX® PLUS. All media plates were incubated in the WASPLab ® and imaged at predefined time points.According to the manual work-up results, the output agreements of the PhenoMATRIX® PLUS for the three results "no growth", "negative", and "Send to Reader" reached 98.5%, 99.6%. and 74.8%, respectively. Importantly, no false negative results were returned by PhenoMATRIX® PLUS in the present study.PhenoMATRIX® PLUS contributes to a significant reduction in the workload. Therefore, technologists' routine tasks have evolved to the confirmatory tests of the presumptively positive colonies, allowing better management of the laboratory staff and the resources.
Keywords: PhenoMATRIX® PLUS, CPOS, MDROs, ESBL-E, Acinetobacter, VRE, Chromogenic media, WASPLab®
Received: 07 May 2025; Accepted: 25 Jun 2025.
Copyright: © 2025 CHERKAOUI, Renzi, Tittel-Elmer and Schrenzel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Abdessalam CHERKAOUI, Hôpitaux universitaires de Genève (HUG), Genève, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.